• Roche Shuts Down Third-Generation NGS Research Programs

    Bio-IT World | News that Roche is merging and laying off some 170 workers in Germany and Branford, CT, does not bode well for its efforts to reclaim some momentum in next-generation sequencing.

    Apr 23, 2013

  • AstraZeneca Builds Up Swedish R&D Potential

    Bio-IT World | Astra Zeneca continues to build up its R&D potential. The company announced its plans to strengthen its relationship with the Stockholm-based Karolinska Institute (KI), one of Europe's largest and most prestigious medical universities.

    Apr 23, 2013

  • Big Investments Behind Precision Medicine

    New York Times | Major medical centers are gearing up for a push for precision medicine. Skeptics would claim it's all a bit premature. But Robert C. Green at Brigham and Women’s Hospital in Boston counters, "What was there to look up on the Internet when the first person got a personal computer? Very little.”

    Apr 23, 2013

  • Deanna Church on the Reference Genome Past, Present and Future

    Bio-IT World | Few have spent as much time gazing upon the Reference as Deanna Church at the National Center for Biotechnology Information. Bio-IT World editor Kevin Davies skyped with Church to hear her personal assessment of the current state of the Reference, the degree of progress in the past decade and priorities for the future.

    Apr 21, 2013

  • Big Biotech Growing Faster than Big Pharma Says Burrill Report

    PharmaTimes | A new report from Burrill, says that Big Biotech has outpaced Big Pharma in terms of growth of sales, income, investment in R&D and market cap during the past three years.

    Apr 19, 2013

  • Cycle Computing Releases Data Transfer and Storage Solution

    Bio-IT World | Cycle Computing has announced the release of DataManager, a new solution that schedules and manages the secure transfer and storage of data sets needed for large scale computations from lower cost cloud storage solutions, such as Amazon Glacier.

    Apr 18, 2013

  • Flying Cars and Adaptive Drug Design: What are the Big Promises for Drug Discovery

    Bio-IT World | BOSTON—As the opening keynote at the 2013 Bio-IT World Conference & Expo, Andrew Hopkins started with the hard questions: Where are the flying cars?

    Apr 18, 2013

  • Challenges of Software Licensing in the Cloud

    ComputerWorld | Software licenses for the Cloud present their own, unique challenges. Infrastructure as a service (IaaS) and platform as a service (PaaS) present the most problems because the customer has shared control over what is run in the cloud environment.

    Apr 18, 2013

  • Out With Cloud, In With Big Data

    ReadWrite | The cloud is officially boring, analysts say. Based on Google search data, the next big thing? Big data.

    Apr 18, 2013

  • Genomics Tools for Myeloma Research

    FastCompany | Kathi Giusti and John Quackenbush discuss the number-one problem in pharma--data kept within the walls of the academic centers and within companies--and what to do about it.

    Apr 17, 2013

  • Open Science, Open Data, Open Access

    Bio-IT World | BOSTON–In two compelling presentations at the Bio-IT World Conference* last week, Atul Butte and Steven Salzberg provided formidable advocacy for the virtues of open data and open science.

    Apr 16, 2013

  • BGI's Kung Fu Aspirations

    Asian Scientist | If BGI had a representative mascot, what would it be? The kung fu panda, naturally. Why? "It is humble, nice, good-looking, cute, soft, but knows kung fu," Wang Jun explains.

    Apr 16, 2013

  • IBM's Billion Dollar Flash Investment

    eWeek | Last week IBM announced a $1 billion investment in flash-based storage for servers, storage systems, and middleware. Big Blue also announced a line of products called FlashSystem and 12 new Centers of Competency around flash storage.

    Apr 15, 2013

  • US Government Not Targeting Exascale Computing

    HPC Wire | The federal R&D budget numbers did not save room for exascale computing. Many had expected the exascale goal to be quietly shelved in light of the sequester, but there were some compute budget gains.

    Apr 15, 2013

  • Thermo Fisher Buys Life Tech for $13.6 Billion

    Forbes | Thermo Fisher Scientific agreed this morning to buy Life Technologies in a $13.6 billion deal or $76/share. It's the largest acquisition ever for Thermo Fisher.

    Apr 15, 2013

  • April 11: News and Notes from the Expo Floor

    Bio-IT World | The 2013 Bio-IT World Conference & Expo closed yesterday--an energetic three days as members from the life sciences and biotech industries convened in Boston. With over 125 exhibitors and 12 tracks, the event is fully-packed. Here are some highlights from a very busy Expo floor.

    Apr 12, 2013

  • Obama’s BRAIN Waves

    Bio-IT World | Guest Commentary | Some three decades ago, a distinguished physiologist suggested that we needed new technologies to record many neurons in parallel. It did not take much imagination to realize that what would be illuminatory with many neurons would be revelatory for the whole brain. This month, President Obama announced the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative, and proponents of the idea hope it will be just that.

    Apr 10, 2013

  • 2013 Bio-IT World Best of Show Winners Named

    Bio-IT World  | The Bio-IT World Best of Show Awards were announced tonight at the 2013 Bio-IT World Conference and Expo in Boston. New products were recognized from ePharmaSolutions, Bright Computing, Seven Bridges Genomics, and Biofortis.

    Apr 10, 2013

  • 2013 Best Practices Awards Winners Named

    Bio-IT World | Bio-IT World announced the winners of its ninth Best Practices Awards competition this morning in a plenary session at the 2013 Bio-IT World Conference & Expo in Boston. Grand prize winners were named in four life sciences categories highlighting best practices in genomics, cloud computing, big data in disease research, and big pharma data management. In addition, a Judges’ Prize and Editors’ Choice Award were given.

    Apr 10, 2013

  • Better Integrating Pharma with CRO Partners

    Bio-IT World | Contributed Commentary | Today’s pharmaceutical industry embraces the electronic laboratory notebook (ELN) as a staple within its labs. Deployments have helped reduce paper, generate efficiencies, provide greater visibility to data, drive standardization and increase collaboration. Within major pharmaceutical companies, the ELN has been a tremendous tool for driving productivity and accelerating the discoveries that speed new and improved drugs to market. Our next focus, as ELN vendors, must be to improve the integration of electronic data capture and sharing with our pharmaceutical customers’ external client systems.

    Apr 9, 2013